# __Spannr 2022 Longevity Funding Report: Record Investment in Aging Interventions__, (from page [20220128](https://kghosh.substack.com/p/20220128).)

__[External link](https://spannr.com/reports/2022-longevity-funding)__



## Keywords

* Spannr
* 2022 Longevity Funding Report
* biotechnology
* aging
* funding rounds
* venture market
* Altos Labs

## Themes

* longevity funding
* venture capital
* startup ecosystem
* aging interventions
* biotechnology

## Other

* Category: science
* Type: research article

## Summary

The Spannr 2022 Longevity Funding Report reveals a record-breaking $6.96 billion raised across 96 funding rounds for longevity startups. Altos Labs, a biotechnology company focused on cellular rejuvenation, accounted for a staggering $3 billion of this total, representing 43% of all funding. The United States dominated the market with 75% of the funding rounds, while Series A and Seed financing were the most common types of raises. The report highlights a strong interest in longevity despite a bearish macroeconomic climate, indicating a robust and growing sector in the aging intervention industry. The data indicates a median deal size of $15 million, with an average financing round size of $75.5 million, although this average is skewed by Altos Labs' significant raise.

## Signals

| name                                                    | description                                                                                 | change                                                                                        | 10-year                                                                                                  | driving-force                                                                         |   relevancy |
|:--------------------------------------------------------|:--------------------------------------------------------------------------------------------|:----------------------------------------------------------------------------------------------|:---------------------------------------------------------------------------------------------------------|:--------------------------------------------------------------------------------------|------------:|
| Surge in Longevity Funding                              | Record-breaking $6.96 billion raised for longevity startups in 2022.                        | Shift from limited funding in aging research to substantial investment in longevity startups. | Aging-related innovations might lead to significant lifespan extension and quality of life improvements. | Growing awareness and understanding of aging biology and potential for interventions. |           5 |
| Emergence of Longevity as a Distinct Industry           | Longevity is now recognized as a separate industry from broader biotech and healthcare.     | Transition from aging research being overlooked to its recognition as a key industry.         | Longevity may evolve into a dominant sector influencing healthcare and personal wellness.                | Increased investment and innovation in aging interventions and technologies.          |           4 |
| Dominance of US in Longevity Funding                    | The US accounted for 75% of total funding in the longevity sector in 2022.                  | Shift of longevity research and funding focus towards the United States.                      | Potential for the US to become the leader in global aging research and technologies.                     | Strong venture capital interest and a robust entrepreneurial ecosystem in the US.     |           4 |
| Rise of Seed and Series A Rounds                        | 55% of funding rounds in 2022 were at Seed or Series A stages.                              | Growth in early-stage investments in longevity startups compared to previous years.           | More startups may emerge, focusing on innovative approaches to aging and longevity.                      | Increased investor confidence in the longevity sector as a viable market.             |           4 |
| Impact of Altos Labs' Funding                           | Altos Labs raised $3 billion, making up 43% of total funds raised in 2022.                  | Shift in funding landscape due to one company's massive funding round.                        | Potential monopolization of cellular rejuvenation research by major players like Altos Labs.             | Significant investor interest in cellular rejuvenation technologies.                  |           4 |
| Resilience of Longevity Sector Amid Economic Challenges | Longevity startups continued to attract investment despite a bearish macroeconomic climate. | From vulnerability in biotech funding to resilience in the longevity sector.                  | Longevity investments may become more stable and reliable in uncertain economic times.                   | Investors seeking long-term growth opportunities in the longevity market.             |           5 |

## Behaviors

| name                                          | description                                                                                                                                    |   relevancy |
|:----------------------------------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------|------------:|
| Increased Investment in Longevity Startups    | There is a significant influx of capital into longevity startups, signaling a growing investor interest in aging interventions.                |           5 |
| Shift Towards Distinct Longevity Industry     | Longevity is being recognized as a separate industry from biotech and healthcare, highlighting its unique market potential.                    |           4 |
| Focus on Early-Stage Funding                  | A majority of funding rounds are at Seed and Series A stages, indicating a focus on early-stage companies in the longevity sector.             |           4 |
| Dominance of US in Longevity Funding          | The United States is leading in longevity-related funding, suggesting a concentration of innovation and investment in this region.             |           4 |
| Rise of Cellular Rejuvenation Technologies    | Companies like Altos Labs are pioneering cellular rejuvenation, pointing to a trend in advanced aging interventions.                           |           5 |
| Market Resilience Despite Economic Challenges | The ability of longevity biotech to attract funding during bearish economic conditions shows resilience and confidence in the sector's future. |           5 |
| Data-Driven Community Engagement              | Spannr is empowering the community with data and tools to foster awareness and growth in the longevity market.                                 |           3 |

## Technologies

| description                                                                                                        |   relevancy | src                              |
|:-------------------------------------------------------------------------------------------------------------------|------------:|:---------------------------------|
| A biotechnology process aimed at reversing aging at the cellular level, exemplified by companies like Altos Labs.  |           5 | cf3c921bb1bef1b55c7d67ea712f9a1b |
| Innovative approaches and technologies focused on modifying the aging process to improve longevity and healthspan. |           4 | cf3c921bb1bef1b55c7d67ea712f9a1b |
| Development of new pharmaceuticals specifically targeting age-related diseases and conditions.                     |           4 | cf3c921bb1bef1b55c7d67ea712f9a1b |
| Research initiatives focused on understanding and improving longevity through clinical trials and studies.         |           4 | cf3c921bb1bef1b55c7d67ea712f9a1b |
| Technologies designed to reduce or reverse signs of aging, enhancing quality of life as people age.                |           4 | cf3c921bb1bef1b55c7d67ea712f9a1b |

## Issues

| name                                   | description                                                                                                                                            |   relevancy |
|:---------------------------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------|------------:|
| Investment Surge in Longevity Startups | A significant increase in funding for longevity startups indicates growing interest and potential in aging interventions and technologies.             |           5 |
| Shift in Aging Research Paradigms      | A growing body of research questioning the inevitability of aging suggests new approaches and potential breakthroughs in the field.                    |           4 |
| Geographic Concentration of Funding    | The dominance of US-based longevity startups in funding rounds highlights regional disparities in investment and innovation.                           |           3 |
| Emerging Longevity Market              | The establishment of longevity as a distinct industry signifies a shift in how aging and biotechnology are perceived and addressed.                    |           4 |
| Impact of Economic Climate on Funding  | The influence of macroeconomic conditions on funding trends for longevity startups could affect future investments and market stability.               |           4 |
| Role of Major Investors                | The involvement of high-profile investors like Bezos in longevity startups raises questions about the future direction and priorities of the industry. |           4 |
| Early Stage Funding Trends             | The predominance of Seed and Series A funding rounds suggests a nascent industry with many startups still in early development phases.                 |           4 |